| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NRMICRO.2016.142 |
| P698 | PubMed publication ID | 27694885 |
| P50 | author | Philip Hugenholtz | Q28219811 |
| Matthew A. Cooper | Q41772215 | ||
| Shaan Gellatly | Q56285639 | ||
| Mark Morrison | Q61783706 | ||
| P2093 | author name string | Philip M Hansbro | |
| Kurtis F Budden | |||
| David L A Wood | |||
| P2860 | cites work | Temporal trends in the incidence of multiple sclerosis: a systematic review | Q22241655 |
| Defining the molecular basis for the first potent and selective orthosteric agonists of the FFA2 free fatty acid receptor | Q24338567 | ||
| Microbial exposure during early life has persistent effects on natural killer T cell function | Q24604308 | ||
| A human gut microbial gene catalogue established by metagenomic sequencing | Q24618931 | ||
| Structure, function and diversity of the healthy human microbiome | Q24626370 | ||
| Hay fever, hygiene, and household size | Q24674856 | ||
| Regulation of lung immunity and host defense by the intestinal microbiota | Q26779232 | ||
| The Altered Schaedler Flora: Continued Applications of a Defined Murine Microbial Community | Q26795708 | ||
| Pulmonary-intestinal cross-talk in mucosal inflammatory disease | Q27693862 | ||
| Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosis | Q28386104 | ||
| Early-Life Exposure to Clostridium leptum Causes Pulmonary Immunosuppression | Q28393820 | ||
| Lipopolysaccharide (LPS) regulation of the immune response: T lymphocytes from normal mice suppress mitogenic and immunogenic responses to LPS | Q72074360 | ||
| Respiratory symptoms and pulmonary functional changes in patients with irritable bowel syndrome | Q73931166 | ||
| Siblings, day-care attendance, and the risk of asthma and wheezing during childhood | Q74212890 | ||
| Increased prevalence of irritable bowel syndrome in patients with bronchial asthma | Q78852531 | ||
| Inverse associations of Helicobacter pylori with asthma and allergy | Q80201603 | ||
| Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae | Q81470399 | ||
| Cigarette smoke decreases organic acids levels and population of bifidobacterium in the caecum of rats | Q84236971 | ||
| Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells | Q84357754 | ||
| Effect of oral feeding with Clostridium leptum on regulatory T-cell responses and allergic airway inflammation in mice | Q84865277 | ||
| Cigarette smoking is associated with intestinal barrier dysfunction in the small intestine but not in the large intestine of mice | Q85283158 | ||
| Effects of cigarette smoke condensate on the production and characterization of exopolysaccharides by Bifidobacterium | Q85349548 | ||
| Association of Helicobacter pylori infection with chronic obstructive pulmonary disease and chronic bronchitis: a meta-analysis of 16 studies | Q41396827 | ||
| Consecutive oral administration of Bifidobacterium longum MM-2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model | Q41659643 | ||
| Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology | Q41758607 | ||
| The impact of asthma on the gastrointestinal tract (GIT). | Q41999409 | ||
| The relationship between bifidobacteria and allergic asthma and/or allergic dermatitis: a prospective study of 0-3 years-old children in Turkey | Q42213060 | ||
| Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial | Q42262026 | ||
| Exacerbation of cigarette smoke-induced pulmonary inflammation by Staphylococcus aureus enterotoxin B in mice | Q42777927 | ||
| Early innate immunity to bacterial infection in the lung is regulated systemically by the commensal microbiota via nod-like receptor ligands | Q43045648 | ||
| Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals | Q44766202 | ||
| Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections | Q46436677 | ||
| Airway Microbiota Determines Innate Cell Inflammatory or Tissue Remodeling Profiles in Lung Transplantation | Q46539385 | ||
| Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability | Q46697141 | ||
| Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut. | Q46720733 | ||
| Components of Streptococcus pneumoniae suppress allergic airways disease and NKT cells by inducing regulatory T cells. | Q47965654 | ||
| Cigarette smoking alters epithelial apoptosis and immune composition in murine GALT. | Q49063503 | ||
| Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination | Q50119689 | ||
| Daily intake of Lactobacillus casei Shirota increases natural killer cell activity in smokers. | Q50263904 | ||
| Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. | Q54348400 | ||
| Commensal microflora contribute to host defense against Escherichia coli pneumonia through Toll-like receptors. | Q54382753 | ||
| Atopic Dermatitis | Q56688397 | ||
| Commensal microbiota induce LPS hyporesponsiveness in colonic macrophages via the production of IL-10 | Q58363356 | ||
| Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy | Q61988333 | ||
| Lipopolysaccharide (LPS) regulation of the immune response: LPS influence on oral tolerance induction | Q70566320 | ||
| Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 | Q28509150 | ||
| From lifetime to evolution: timescales of human gut microbiota adaptation | Q28652725 | ||
| Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome | Q28821251 | ||
| A microbial symbiosis factor prevents intestinal inflammatory disease | Q29614263 | ||
| Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells | Q29618126 | ||
| Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota | Q29618128 | ||
| Early infancy microbial and metabolic alterations affect risk of childhood asthma | Q30066441 | ||
| The rise of childhood type 1 diabetes in the 20th century. | Q30332258 | ||
| Early intestinal Bacteroides fragilis colonisation and development of asthma | Q33372440 | ||
| Asthma is inversely associated with Helicobacter pylori status in an urban population | Q33396229 | ||
| Human pathogens abundant in the bacterial metagenome of cigarettes | Q33523227 | ||
| Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13 | Q33557513 | ||
| Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis | Q33744938 | ||
| Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3 | Q33789758 | ||
| Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces | Q33927605 | ||
| Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10. | Q34060888 | ||
| Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey | Q34094839 | ||
| The 'hygiene hypothesis' for autoimmune and allergic diseases: an update | Q34111851 | ||
| Isolation of Succinivibrionaceae implicated in low methane emissions from Tammar wallabies | Q34196704 | ||
| TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination | Q34216832 | ||
| Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma | Q34261744 | ||
| Microbiota-mediated colonization resistance against intestinal pathogens | Q34324937 | ||
| The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism | Q34355154 | ||
| House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection | Q34392336 | ||
| The function of our microbiota: who is out there and what do they do? | Q34392557 | ||
| Perinatal antibiotic-induced shifts in gut microbiota have differential effects on inflammatory lung diseases | Q34434457 | ||
| The lung microbiome in moderate and severe chronic obstructive pulmonary disease | Q34448176 | ||
| Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation | Q34533098 | ||
| Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome. | Q34701085 | ||
| Microbiota regulates the TLR7 signaling pathway against respiratory tract influenza A virus infection. | Q34724765 | ||
| Microbiota regulates immune defense against respiratory tract influenza A virus infection | Q34750186 | ||
| Helicobacter pylori colonization is inversely associated with childhood asthma | Q34791821 | ||
| Numerical ecology validates a biogeographical distribution and gender-based effect on mucosa-associated bacteria along the human colon | Q35018848 | ||
| Low gut microbiota diversity in early infancy precedes asthma at school age. | Q35065097 | ||
| Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis | Q35081904 | ||
| Comparison of the respiratory microbiome in healthy nonsmokers and smokers | Q37073006 | ||
| Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. | Q37229478 | ||
| Dysregulation of gastric H,K-ATPase by cigarette smoke extract | Q37318564 | ||
| Harnessing regulatory T cells to suppress asthma: from potential to therapy | Q37680540 | ||
| Longitudinal study of murine microbiota activity and interactions with the host during acute inflammation and recovery | Q37718507 | ||
| Helminths in the hygiene hypothesis: sooner or later? | Q38205868 | ||
| Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂. | Q38311200 | ||
| Disturbed intestinal integrity in patients with COPD: effects of activities of daily living | Q38313534 | ||
| Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation | Q38578579 | ||
| Transient TLR activation restores inflammatory response and ability to control pulmonary bacterial infection in germfree mice | Q39291435 | ||
| Cigarette smoke increases Staphylococcus aureus biofilm formation via oxidative stress. | Q39297856 | ||
| Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. | Q40679116 | ||
| Gut microbiota and protection from pneumococcal pneumonia | Q40731595 | ||
| Control of Klebsiella pneumoniae pulmonary infection and immunomodulation by oral treatment with the commensal probiotic Bifidobacterium longum 5(1A). | Q40918154 | ||
| Effect of Lactobacillus paracasei subsp. paracasei, L. casei 431 on immune response to influenza vaccination and upper respiratory tract infections in healthy adult volunteers: a randomized, double-blind, placebo-controlled, parallel-group study. | Q41271736 | ||
| Pharmacological properties of acid N-thiazolylamide FFA2 agonists. | Q41359686 | ||
| Specialized metabolites from the microbiome in health and disease | Q35111744 | ||
| Cigarette smoke condensate increases C. albicans adhesion, growth, biofilm formation, and EAP1, HWP1 and SAP2 gene expression | Q35117249 | ||
| Bacterial capsular polysaccharide prevents the onset of asthma through T-cell activation | Q35119767 | ||
| Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals | Q35172371 | ||
| Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH. | Q35214931 | ||
| Dietary pectin-derived acidic oligosaccharides improve the pulmonary bacterial clearance of Pseudomonas aeruginosa lung infection in mice by modulating intestinal microbiota and immunity. | Q35228287 | ||
| Innate immune responses to mycobacteria and the downregulation of atopic responses. | Q35539327 | ||
| High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6. | Q35574840 | ||
| Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. | Q35611410 | ||
| Use of Germ-Free Animal Models in Microbiota-Related Research | Q35648881 | ||
| Whey peptide-based enteral diet attenuated elastase-induced emphysema with increase in short chain fatty acids in mice | Q35658791 | ||
| Helicobacter pylori neutrophil-activating protein: a potential Treg modulator suppressing allergic asthma? | Q35669957 | ||
| Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites | Q35671726 | ||
| Helicobacter urease-induced activation of the TLR2/NLRP3/IL-18 axis protects against asthma | Q35716248 | ||
| Intestinal Microbiota of Mice Influences Resistance to Staphylococcus aureus Pneumonia. | Q35717842 | ||
| Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid | Q35742145 | ||
| Anti-Inflammatory Effects of Lactobacillus Rahmnosus and Bifidobacterium Breve on Cigarette Smoke Activated Human Macrophages | Q35758923 | ||
| Gut biogeography of the bacterial microbiota | Q35820919 | ||
| The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. | Q35825316 | ||
| The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate Allergic Inflammation. | Q35828936 | ||
| The Gut-Lung Axis in Respiratory Disease | Q35848701 | ||
| Allergic Patients with Long-Term Asthma Display Low Levels of Bifidobacterium adolescentis | Q35913465 | ||
| The Microbiome in Cystic Fibrosis | Q35917770 | ||
| Allergy associations with the adult fecal microbiota: Analysis of the American Gut Project | Q35921853 | ||
| Patent watch: Modulating the human microbiome with live biotherapeutic products: intellectual property landscape | Q35975853 | ||
| The lung tissue microbiome in chronic obstructive pulmonary disease | Q35987112 | ||
| Characterisation of the gastrointestinal mucosa-associated microbiota: a novel technique to prevent cross-contamination during endoscopic procedures | Q35992014 | ||
| Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity | Q36002388 | ||
| Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans | Q36004640 | ||
| Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals | Q36070143 | ||
| Dietary lactosucrose suppresses influenza A (H1N1) virus infection in mice | Q36302156 | ||
| Helicobacter pylori-Mediated Protection from Allergy Is Associated with IL-10-Secreting Peripheral Blood Regulatory T Cells. | Q36656498 | ||
| Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma | Q36677096 | ||
| A comparative study of bifidobacteria in human babies and adults | Q36875930 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 55-63 | |
| P577 | publication date | 2016-10-03 | |
| P1433 | published in | Nature Reviews Microbiology | Q1071797 |
| P1476 | title | Emerging pathogenic links between microbiota and the gut-lung axis | |
| P478 | volume | 15 |
| Q98944137 | A protein interaction map identifies existing drugs targeting SARS-CoV-2 |
| Q42684010 | Abnormal M1/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD). |
| Q37715936 | Alterations of the murine gut microbiome in allergic airway disease are independent of surfactant protein D |
| Q91703665 | Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System |
| Q92409537 | Applications of the Soil, Plant and Rumen Microbiomes in Pastoral Agriculture |
| Q33692100 | Attenuating immune pathology using a microbial-based intervention in a mouse model of cigarette smoke-induced lung inflammation. |
| Q45849451 | Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota. |
| Q92562281 | Bowel movement frequency and risks of major vascular and non-vascular diseases: a population-based cohort study among Chinese adults |
| Q64226775 | Cell type and receptor identity regulate cholera toxin subunit B (CTB) internalization |
| Q53692990 | Characterisation of Bergeyella spp. isolated from the nasal cavities of piglets. |
| Q60302729 | Characterisation of small molecule ligands 4CMTB and 2CTAP as modulators of human FFA2 receptor signalling |
| Q58613950 | Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities |
| Q50054942 | Chronic cigarette smoke exposure induces systemic hypoxia that drives intestinal dysfunction. |
| Q61807050 | Cigarette Smoke Induces Intestinal Inflammation via a Th17 Cell-Neutrophil Axis |
| Q91898135 | Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study |
| Q90197136 | Comparative analysis of the fecal microbiota from different species of domesticated and wild suids |
| Q50320976 | Cow's Milk and Immune Function in the Respiratory Tract: Potential Mechanisms |
| Q92126935 | Critical symbiont signals drive both local and systemic changes in diel and developmental host gene expression |
| Q92209623 | Current Findings on Gut Microbiota Mediated Immune Modulation against Viral Diseases in Chicken |
| Q36321884 | Dendritic cell expression of the signaling molecule TRAF6 is required for immune tolerance in the lung |
| Q42718218 | Desired Turbulence? Gut-Lung Axis, Immunity, and Lung Cancer |
| Q47425953 | Development of severe bronchopulmonary dysplasia is associated with alterations in fecal volatile organic compounds |
| Q49982245 | Diet Pattern and Respiratory Morbidity in the Atherosclerosis Risk in Communities Study. |
| Q57072837 | Diet, Microbiota and Gut-Lung Connection |
| Q91883877 | Differences in gut microbiome composition between persons with chronic schizophrenia and healthy comparison subjects |
| Q102152156 | Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease |
| Q28072332 | Dissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal Models |
| Q90599331 | Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer |
| Q59791862 | Dysbiosis of the Salivary Microbiome Is Associated With Non-smoking Female Lung Cancer and Correlated With Immunocytochemistry Markers |
| Q47105946 | Early-Life Human Microbiota Associated With Childhood Allergy Promotes the T Helper 17 Axis in Mice |
| Q64921507 | Effects of Lactobacillus plantarum 15-1 and fructooligosaccharides on the response of broilers to pathogenic Escherichia coli O78 challenge. |
| Q64260586 | Effects of Mediterranean Diet and Physical Activity on Pulmonary Function: A Cross-Sectional Analysis in the ILERVAS Project |
| Q64261748 | Elevated Gut Microbiome-Derived Propionate Levels Are Associated With Reduced Sterile Lung Inflammation and Bacterial Immunity in Mice |
| Q40218877 | Emphysema and soluble CD14 are associated with pulmonary nodules in HIV-infected patients: implications for lung cancer screening |
| Q59411245 | Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention |
| Q47273537 | Eosinophils promote inducible NOS-mediated lung allograft acceptance |
| Q91786395 | Examining the Complex Relationship Between Tuberculosis and Other Infectious Diseases in Children |
| Q90329537 | Exploring the microbiota of upper respiratory tract during the development of pneumonia in a mouse model |
| Q97587391 | Fecal microbial transplantation and a high fiber diet attenuates emphysema development by suppressing inflammation and apoptosis |
| Q61812034 | Feeding intolerance alters the gut microbiota of preterm infants |
| Q47115632 | First Report of Swim Bladder-Associated Microbiota in Rainbow Trout (Oncorhynchus mykiss). |
| Q92219510 | Fungal-Bacterial Interactions in Health and Disease |
| Q98199255 | Gastrointestinal and hepatic manifestations of Corona Virus Disease-19 and their relationship to severe clinical course: A systematic review and meta-analysis |
| Q40091539 | Global health: Probiotic prevents infections in newborns |
| Q88511725 | Granulocyte-CSF links destructive inflammation and comorbidities in obstructive lung disease |
| Q54213057 | Gut Microbiota Contributes to Resistance Against Pneumococcal Pneumonia in Immunodeficient Rag-/- Mice. |
| Q55029540 | Gut Microbiota: An Integral Moderator in Health and Disease. |
| Q50096372 | Gut microbiome contributes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers |
| Q87628212 | Gut microbiota: Neonatal gut microbiota induces lung immunity against pneumonia |
| Q40096295 | Helicobacter pylori and its secreted immunomodulator VacA protect against anaphylaxis in experimental models of food allergy |
| Q93209134 | Heparin-binding epidermal growth factor (HB-EGF) drives EMT in patients with COPD: implications for disease pathogenesis and novel therapies |
| Q91609670 | Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now? |
| Q107473554 | Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs |
| Q89948598 | Host responses to mucosal biofilms in the lung and gut |
| Q47912511 | Host-microbiota interplay in mediating immune disorders |
| Q92608559 | Houttuynia cordata polysaccharide alleviated intestinal injury and modulated intestinal microbiota in H1N1 virus infected mice |
| Q89664999 | Immune protection is dependent on the gut microbiome in a lethal mouse gammaherpesviral infection |
| Q89030870 | Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study |
| Q93085060 | Immunomodulatory Effects of Lactobacillus plantarum on Inflammatory Response Induced by Klebsiella pneumoniae |
| Q64247644 | Impact of Host Genetics and Biological Response Modifiers on Respiratory Tract Infections |
| Q90606204 | Impact of gut microbiota on gut-distal autoimmunity: a focus on T cells |
| Q87898913 | Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis |
| Q41676206 | Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period |
| Q90382628 | Inflammatory Bowel Disease and Obstructive Pulmonary Disease: A Two-way Association? |
| Q88691581 | Integrative Physiology of Pneumonia |
| Q90479753 | Intestinal Dysbiosis and the Developing Lung: The Role of Toll-Like Receptor 4 in the Gut-Lung Axis |
| Q90320710 | LPS inactivation by a host lipase allows lung epithelial cell sensitization for allergic asthma |
| Q41933677 | Lactobacillus paracasei feeding improves immune control of influenza infection in mice. |
| Q98774532 | Letter: role of probiotics in the COVID-19 pandemic-authors' reply |
| Q59359589 | Lung Dysbiosis, Inflammation, and Injury in Hematopoietic Cell Transplantation |
| Q91893359 | Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer |
| Q57060199 | Making matters worse |
| Q39402899 | Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma. |
| Q100502869 | Mechanisms linking the human gut microbiome to prophylactic and treatment strategies for COVID-19 |
| Q99551237 | Metagenome analysis using serum extracellular vesicles identified distinct microbiota in asthmatics |
| Q60960968 | Methylation of Moderates the Effect of Smoking on Genomewide Methylation Among Middle Age African Americans |
| Q93042013 | Microbes, metabolites, and the gut-lung axis |
| Q37739364 | Microbiome effects on immunity, health and disease in the lung |
| Q39095070 | Microbiomes in respiratory health and disease: An Asia-Pacific perspective |
| Q55424073 | Microbiota Composition and the Integration of Exogenous and Endogenous Signals in Reactive Nasal Inflammation. |
| Q99582945 | Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms |
| Q55356524 | More of the Gut in the Lung: How Two Microbiomes Meet in ARDS. |
| Q92246549 | Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges |
| Q56337956 | Nasal microbiota clusters associate with inflammatory response, viral load, and symptom severity in experimental rhinovirus challenge |
| Q58115403 | Neonatal gut and respiratory microbiota: coordinated development through time and space |
| Q90699508 | Neuroimmunophysiology of the gut: advances and emerging concepts focusing on the epithelium |
| Q52564632 | New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells. |
| Q53698735 | No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases. |
| Q44876695 | Nonsteroidal Anti-Inflammatory Drug-Induced Leaky Gut Modeled Using Polarized Monolayers of Primary Human Intestinal Epithelial Cells. |
| Q64903251 | Novel cancer therapy targeting microbiome. |
| Q99544126 | Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral-bacterial interactions |
| Q52381787 | Of genes and microbes: solving the intricacies in host genomes. |
| Q38661283 | Oral Probiotics Alter Healthy Feline Respiratory Microbiota. |
| Q50535429 | Oral cholera vaccination promotes homing of IgA+ memory B cells to the large intestine and the respiratory tract |
| Q50177789 | Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder |
| Q58729114 | Paradigms of Lung Microbiota Functions in Health and Disease, Particularly, in Asthma |
| Q90732948 | Peptidoglycan Recognition Protein 4 Limits Bacterial Clearance and Inflammation in Lungs by Control of the Gut Microbiota |
| Q90254502 | Point-of-care sensors for the management of sepsis |
| Q47704287 | Potential Role of the Lung Microbiome in Shaping Asthma Phenotypes |
| Q64068374 | Probiotics: current landscape and future horizons |
| Q47152495 | Protective Microbiota: From Localized to Long-Reaching Co-Immunity |
| Q89539385 | Rapid and direct molecular detection of Streptococcus pneumoniae and Haemophilus influenzae isolated in oropharynx and nasal cavity of children |
| Q49569061 | Remote Sensing between Liver and Intestine: Importance of Microbial Metabolites |
| Q92817273 | Role of Diet in Chronic Obstructive Pulmonary Disease Prevention and Treatment |
| Q41987385 | Role of microbiota on lung homeostasis and diseases. |
| Q98566399 | Role of probiotics to combat viral infections with emphasis on COVID-19 |
| Q64943706 | Roles for T/B lymphocytes and ILC2s in experimental chronic obstructive pulmonary disease. |
| Q97568354 | SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis |
| Q47717478 | Segmented Filamentous Bacteria Provoke Lung Autoimmunity by Inducing Gut-Lung Axis Th17 Cells Expressing Dual TCRs |
| Q91895123 | Smoking and microbiome in oral, airway, gut and some systemic diseases |
| Q40050175 | Steroid resistance and concomitant respiratory infections: A challenging battle in pulmonary clinic. |
| Q92889810 | Supplementation of triple viable probiotics combined with dietary intervention is associated with gut microbial improvement in humans on a high-fat diet |
| Q55514867 | Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System. |
| Q64078671 | Systems biology in inflammatory bowel diseases: on the way to precision medicine |
| Q61797807 | TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis |
| Q90218826 | The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases |
| Q64079680 | The Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients |
| Q59335043 | The Host Microbiota Contributes to Early Protection Against Lung Colonization by |
| Q55025841 | The Human Virome Protein Cluster Database (HVPC): A Human Viral Metagenomic Database for Diversity and Function Annotation. |
| Q41159836 | The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces |
| Q88039580 | The Lung Microbiota of Healthy Mice Are Highly Variable, Cluster by Environment, and Reflect Variation in Baseline Lung Innate Immunity |
| Q51743237 | The Metabolic Sensor GPR43 Receptor Plays a Role in the Control of Klebsiella pneumoniae Infection in the Lung. |
| Q49961321 | The Relationship Between the Human Genome and Microbiome Comes into View |
| Q89787316 | The Role of Lung and Gut Microbiota in the Pathology of Asthma |
| Q90180433 | The developing gut-lung axis: postnatal growth restriction, intestinal dysbiosis, and pulmonary hypertension in a rodent model |
| Q54252513 | The emerging role of the microbiota in the ICU. |
| Q90256874 | The human microbiota in pulmonary tuberculosis: Not so innocent bystanders |
| Q92999518 | The microbiota and immune-mediated diseases: Opportunities for therapeutic intervention |
| Q100752733 | The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19 |
| Q39200222 | The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD. |
| Q97568520 | The use of fecal microbiota transplant in sepsis |
| Q58754447 | Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis |
| Q47565602 | Through the Scope Darkly: The Gut Mycobiome Comes into Focus |
| Q47746183 | Toll-like receptor 2 and 4 have Opposing Roles in the Pathogenesis of Cigarette Smoke-induced Chronic Obstructive Pulmonary Disease |
| Q96303578 | Traumatic Spinal Cord Injury and the Gut Microbiota: Current Insights and Future Challenges |
| Q92063313 | Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China |
| Q64076877 | VacA Targets Myeloid Cells in the Gastric Lamina Propria To Promote Peripherally Induced Regulatory T-Cell Differentiation and Persistent Infection |
Search more.